Header Component — Here-4-You Consulting

HEREDITARY DISEASE FOUNDATION

Financial Information

Total Assets:
$21,978,294
Total Giving:
$2,857,980

Area of Service:

National Scope: Grants are distributed across the U.S

Areas of Interest:

Not Available

Programs

None

Grants

History shows that 65% of their giving goes to support Education, almost 21% goes to Health and 7% goes to Social & Human Services Category.
Grants in recent years include:
$200,000 for Canada;
$199,892 for Australia;
$100,000 for United Kingdom;
$100,000 for Mass General Brigham; and
$100,000 for Children’s Hospital of Philadelphia.

Limitations

None

Summary

The foundation supports and funds innovative, transformative research aimed at curing Huntington’s disease (HD) and advancing understanding and potential treatments for related brain disorders such as Parkinson’s, Alzheimer’s, and Lou Gehrig’s disease (ALS).

Additional

The Hereditary Disease Foundation was established in 1968 by Dr. Milton Wexler in New York.

Quick Facts Sheet
URL:

www.hdfoundation.org

Located in:

New York,

New York

United States

Contact Information / Process

Phone #:
212-928-2121
Fax:
212-928-2172
Email:
carljohnson@hdfoundation.org
Application Address:
Hereditary Disease Foundation
601 West 168th Street, Suite 54
New York, New York 10032
Procedures:
Applicants must submit a letter of inquiry (LOI) in the foundation.
There are no deadlines.

Donors & Leadership

Founder:
Dr. Milton Wexler
Director:
Alice Wexler, Secretary
Anne B Young Md, Vice Chairman
Berta A Gehry, Director
Bruce Donaldson, Treasurer
C Frank Bennett, Director
David Housman, Director
David Zwally, Director
Erica Matisz, Director of Development
Frank O Gehry, Director
Herbert Pardes, Director
Joan Leiman, Director
Julie Porter, Director of Administration
Karen Newman, Chairman
Lauren Baker Pinkus, Director
Leslie M Thompson, Director
Meghan Donaldson, Chief Executive Officer
Melissa Moser, Director
Nancy S Wexler, President
Robi Blumenstein, Director
Sandy Fox, Director
Sarah Hernandez, Director of Research Programs
Tacie Fox, Director
Tim Kelleher, Chief Financial Officer

EIN:

237376197